About Tighe Reardon
Tighe Reardon is an executive officer at AeroRx Therapeutics.
Form D filings also name Tighe Reardon as an executive officer at Enlaza Therapeutics and an executive officer and director at AristaMD.
Tighe Reardon reports to the SEC as an officer or major shareholder of 2 public companies: Janux Therapeutics (JANX) and Synthorx (THOR).
Tighe Reardon first appears on SEC filings in 2015.
Experience
This experience comes from SEC filings. The years are when the filings name Tighe Reardon in the role, so the role may have started earlier or lasted longer.
JI
Janux Therapeutics, Inc.
Acting Chief Financial Officer
2021 – 2024 · Public company (JANX)
SI
Synthorx, Inc.
Acting Chief Financial Officer
2018 – 2020 · Public company (THOR)
Key Colleagues at Startups
The people Tighe Reardon works with at each company, as listed on that company's latest Form D.
AeroRx Therapeutics, Inc. · Form D, Oct 10, 2025
AD
Ahmet Tutuncu, M.D., Ph.D.
Chief Executive Officer and director
HD
Heather Preston, M.D.
Director
JD
Jay Lichter, Ph.D.
Director
JD
John Patton, Ph.D.
Director
SD
Sanford Madigan, Ph.D.
Director
Enlaza Therapeutics, Inc. · Form D, Sep 11, 2025
MM
Marcos Milla
Director
SS
Stephen Squinto
Director
JL
Jay Lichter
Director
SC
Shelley Chu
Director
SD
Sergio Duron
Chief Executive Officer and director
JT
James Topper
Director
SM
Sanford Madigan
Executive officer
AristaMD, Inc. · Form D, Mar 7, 2022
AB
Ann Barnes
Director
BL
Brooke LeVasseur
CEO and director
BH
Brant Heise
Director
CC
Craig Cimini
Director
JK
John Kuelper
Director